Clinical Trial Update: Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma

View source ↗

Summary

Clinical trial update investigating the combination of tislelizumab with gemcitabine and pegaspargase for patients with primary stage I-II Extranodal NK/T-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pegaspargase (pegaspargase)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: ORR, OS | Status: ENROLLING_BY_INVITATION